Article
KIT mutations correlate with adverse survival in children with core-binding factor acute myeloid leukemia.
Leukemia & lymphoma - 1 Apr 2018
Chen Xi, Dou Hu, Wang Xingjuan, Huang Yi, Lu Ling, Bin Junqing, Su Yongchun, Zou Lin, Yu Jie, Bao Liming
Abstract excerpt
The prevalence and clinical relevance of KIT mutations in childhood core-binding factor (CBF) acute myeloid leukemia (AML) have not been well characterized. In this study, a total of 212 children with de novo AML were enrolled from a Chinese population and 50 (23.5%) of the patients were deemed CBF-AML. KIT mutations were identified in 30% of the CBF-AML cohort. The KIT mutations were clustered in exon 17 and...
Topics
Join the communities discussing this publication.
